Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats

European Journal of Pain

Volumn 13, Issue 8, 2009, Pages 807-811

  Wodarski, Rachel ^a   Clark, Anna K ^a   Grist, John ^a   Marchand, Fabien ^a   Malcangio, Marzia ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Allodynia; Astrocytes; Microglia; Neuropathic pain

Indexed keywords

CALCIUM BINDING PROTEIN; CALCIUM BINDING PROTEIN IBA 1; GABAPENTIN; GLIAL FIBRILLARY ACIDIC PROTEIN; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DIABETIC NEUROPATHY; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD DORSAL HORN; STREPTOZOCIN DIABETES;

AMINES; ANALGESICS; ANIMALS; ASTROCYTES; CELL COUNT; CYCLOHEXANECARBOXYLIC ACIDS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PHYSICAL STIMULATION; RATS; RATS, WISTAR; SPINAL CORD;

EID: 67949110917     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2008.09.010     Document Type: Article

References (30)

1. Aizenman Y., and de V.J. Synergistic action of thyroid hormone, insulin and hydrocortisone on astrocyte differentiation. Brain Res 414 (1987) 301-308
2. Beiter T., Artelt M.R., Trautmann K., and Schluesener H.J. Experimental autoimmune neuritis induces differential microglia activation in the rat spinal cord. J Neuroimmunol 160 (2005) 25-31
3. Calcutt N.A., and Chaplan S.R. Spinal pharmacology of tactile allodynia in diabetic rats. Br J Pharmacol 122 (1997) 1478-1482
4. Chaplan S.R., Pogrel J.W., and Yaksh T.L. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther 269 (1994) 1117-1123
5. Coderre T.J., Katz J., Vaccarino A.L., and Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52 (1993) 259-285
6. Colburn R.W., DeLeo J.A., Rickman A.J., Yeager M.P., Kwon P., and Hickey W.F. Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J Neuroimmunol 79 (1997) 163-175
7. Coleman E., Judd R., Hoe L., Dennis J., and Posner P. Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 48 (2004) 166-178
8. Daulhac L., Mallet C., Courteix C., Etienne M., Duroux E., Privat A.M., et al. Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-d-aspartate-dependent mechanisms. Mol Pharmacol 70 (2006) 1246-1254
9. Hendrich J., Van Minh A.T., Heblich F., Nieto-Rostro M., Watschinger K., Striessnig J., et al. Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin PNAS105 (2008) 3928-3933
10. Kawasaki Y., Xu Z.Z., Wang X., Park J.Y., Zhuang Z.Y., Tan P.H., et al. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 14 (2008) 331-336
11. Lechuga-Sancho A.M., Arroba A.I., Frago L.M., Garcia-Caceres C., de Celix A.D., Argente J., et al. Reduction in the number of astrocytes and their projections is associated with increased synaptic protein density in the hypothalamus of poorly controlled diabetic rats. Endocrinology 147 (2006) 5314-5324
12. Luo Z.D., Calcutt N.A., Higuera E.S., Valder C.R., Song Y.H., Svensson C.I., et al. Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther 303 (2002) 1199-1205
13. Luongo L., Sajic M., Grist J., Clark A.K., Maione S., and Malcangio M. Spinal changes associated with mechanical hypersensitivity in a model of Guillain-Barre syndrome. Neurosci Lett 437 (2008) 98-102
14. Malcangio M., and Tomlinson D.R. A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats. Pain 76 (1998) 151-157
15. Maneuf Y.P., Luo Z.D., and Lee K. Alpha2delta and the mechanism of action of gabapentin in the treatment of pain. Semin Cell Dev Biol 17 (2006) 565-570
16. Milligan E.D., O'Connor K.A., Nguyen K.T., Armstrong C.B., Twining C., Gaykema R.P., et al. Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci 21 (2001) 2808-2819
17. Qin M., Wang J.J., Cao R., Zhang H., Duan L., Gao B., et al. The lumbar spinal cord glial cells actively modulate subcutaneous formalin induced hyperalgesia in the rat. Neurosci Res 55 (2006) 442-450
18. Raghavendra V., Tanga F.Y., and DeLeo J.A. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci 20 (2004) 467-473
19. Scholz J., and Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10 (2007) 1361-1368
20. Stahl T., Reimers C., Johne R., Schliebs R., and Seeger J. Viral-induced inflammation is accompanied by beta-amyloid plaque reduction in brains of amyloid precursor protein transgenic Tg2576 mice. Eur J Neurosci 24 (2006) 1923-1934
21. Stefani A., Spadoni F., and Bernardi G. Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology 37 (1998) 83-91
22. Svensson C.I., Fitzsimmons B., Azizi S., Powell H.C., Hua X.Y., and Yaksh T.L. Spinal p38beta isoform mediates tissue injury-induced hyperalgesia and spinal sensitization. J Neurochem 92 (2005) 1508-1520
23. Sweitzer S.M., Colburn R.W., Rutkowski M., and DeLeo J.A. Acute peripheral inflammation induces moderate glial activation and spinal IL-1beta expression that correlates with pain behavior in the rat. Brain Res 829 (1999) 209-221
24. Sweitzer S.M., Medicherla S., Almirez R., Dugar S., Chakravarty S., Shumilla J.A., et al. Antinociceptive action of a p38alpha MAPK inhibitor, SD-282, in a diabetic neuropathy model. Pain 109 (2004) 409-419
25. Tsuda M., Inoue K., and Salter M.W. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 28 (2005) 101-107
26. Tsuda M., Ueno H., Kataoka A., Tozaki-Saitoh H., and Inoue K. Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signal-regulated protein kinase signaling. Glia 56 (2008) 378-386
27. Vinik A. Clinical review: Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J Clin Endocrinol Metab 90 (2005) 4936-4945
28. Watkins L.R., and Maier S.F. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov 2 (2003) 973-985
29. Xiao W., Boroujerdi A., Bennett G.J., and Luo Z.D. Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit. Neuroscience 144 (2007) 714-720
30. Yusaf S.P., Goodman J., Gonzalez I.M., Bramwell S., Pinnock R.D., Dixon A.K., et al. Streptozocin-induced neuropathy is associated with altered expression of voltage-gated calcium channel subunit mRNAs in rat dorsal root ganglion neurones. Biochem Biophys Res Commun 289 (2001) 402-406